Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening? (Pagedocc2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01279330|
Recruitment Status : Unknown
Verified September 2010 by University of Paris 5 - Rene Descartes.
Recruitment status was: Recruiting
First Posted : January 19, 2011
Last Update Posted : January 19, 2011
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Cancer||Other: Co-signed Letter Other: Control||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1569 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening? A Cluster Randomised Controlled Study.|
|Study Start Date :||September 2010|
|Estimated Primary Completion Date :||April 2011|
|Estimated Study Completion Date :||April 2011|
No Intervention: Control
Patients receive by mail the materials needed for stool samples.
No intervention (Patients receive by mail the materials needed for stool samples).
|Experimental: Co-signed Letter||
Other: Co-signed Letter
Patients receive a personalized stimulus letter co-signed by their general practitioner and the medical coordinator of ADECA.
- Completion of Fecal Occult Blod Test [ Time Frame: 7 months ]Increased number of patients who completed the test for faecal occult blood following the first solicitation with the letter co-signed by general practitioner, compared with the conventional solicition(including replies exclusions).
- Delays from receipt of the letter and the completion of the test. [ Time Frame: 7 months ]
- Proportion of uninterpretable test. [ Time Frame: 7 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01279330
|Contact: Serge Gilberg||01 44 41 23 email@example.com|
|Université Paris Descartes||Recruiting|
|Paris, Ile de France, France, 75014|
|Contact: Barthe 01 44 41 23 63 firstname.lastname@example.org|